Biologic drugs for treatment of macrophage activation syndrome

Bhaskar Dasgupta

Are biologic drugs used in the treatment of macrophage activation syndrome?

Bhaskar Dasgupta, MD: At the moment we do not use biologics apart from anakinra, which is generally used in Still disease, in systemic juvenile idiopathic arthritis (JIA), for interleukin 1 inhibition, and that is quite effective. Tocilizumab has been used in systemic JIA but paradoxically it has also been incriminated in causing macrophage activation syndrome in a few cases.

We would love to hear from you

  • Do you have any comments?
  • Have you found a mistake?
  • Would you like to suggest a feature?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.